AGPAT4
Basic information
Region (hg38): 6:161129967-161274061
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AGPAT4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 10 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 1 | 0 |
Variants in AGPAT4
This is a list of pathogenic ClinVar variants found in the AGPAT4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-161136601-G-A | not specified | Uncertain significance (Jun 19, 2024) | ||
6-161139560-G-A | not specified | Uncertain significance (May 31, 2023) | ||
6-161139569-T-C | not specified | Uncertain significance (May 10, 2023) | ||
6-161139592-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
6-161146562-C-T | not specified | Likely benign (Oct 29, 2021) | ||
6-161146595-T-A | not specified | Uncertain significance (Jan 10, 2023) | ||
6-161149206-G-C | not specified | Uncertain significance (Apr 19, 2023) | ||
6-161153414-C-T | not specified | Uncertain significance (Jun 22, 2024) | ||
6-161154202-T-G | not specified | Uncertain significance (Jan 31, 2022) | ||
6-161154241-C-T | not specified | Uncertain significance (May 25, 2022) | ||
6-161232086-T-G | not specified | Uncertain significance (Mar 04, 2024) | ||
6-161232156-C-G | not specified | Uncertain significance (Aug 13, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AGPAT4 | protein_coding | protein_coding | ENST00000320285 | 8 | 144083 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.102 | 0.898 | 125741 | 0 | 7 | 125748 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.23 | 136 | 231 | 0.588 | 0.0000146 | 2464 |
Missense in Polyphen | 40 | 82.009 | 0.48775 | 839 | ||
Synonymous | 0.958 | 88 | 100 | 0.878 | 0.00000691 | 725 |
Loss of Function | 3.19 | 6 | 22.2 | 0.270 | 0.00000130 | 219 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000909 | 0.0000909 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000265 | 0.0000264 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone. {ECO:0000250}.;
- Pathway
- Glycerolipid metabolism - Homo sapiens (human);Glycerophospholipid metabolism - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Triacylglyceride Synthesis;Metabolism of lipids;Metabolism;CDP-diacylglycerol biosynthesis;triacylglycerol biosynthesis;Glycerophospholipid biosynthesis;Phospholipid metabolism;Synthesis of PA
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.212
- rvis_EVS
- -0.51
- rvis_percentile_EVS
- 21.41
Haploinsufficiency Scores
- pHI
- 0.323
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.517
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.972
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Agpat4
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; normal phenotype; skeleton phenotype;
Gene ontology
- Biological process
- phospholipid metabolic process;phosphatidic acid biosynthetic process;phospholipid biosynthetic process;CDP-diacylglycerol biosynthetic process;macromolecule metabolic process
- Cellular component
- mitochondrial outer membrane;endoplasmic reticulum membrane;integral component of membrane
- Molecular function
- 1-acylglycerol-3-phosphate O-acyltransferase activity;protein binding;transferase activity, transferring acyl groups